摘要
A recent study by Irene Caffa and colleagues published in Nature demonstrated that fasting-mimicking diet(FMD)could enhance the effect of endocrine therapeutics(ET)tamoxifen and fulvestrant for breast cancer(BC)and reduce their side effects,which might provide a new adjunct to endocrine therapy for BC1.
基金
supported in part by award numbers 81872028 and 81672693(H.M.)
from the National Natural Science Foundation of China,cstc2017jcyjBX0071(H.M.)
from the Foundation and Frontier Research Project of Chongqing and T04010019(H.M.)
from the Chongqing Youth Top Talent Project.
